Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

NCT01661634 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2157

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Decompensated Heart Failure

Interventions

DRUG: Ularitide
DRUG: Placebo

Sponsor

Cardiorentis

Collaborators

[object Object]